Below you will find basic demographic and healthcare market data on China, plus specific information about the medical device and healthcare industries.
Overview of medical device industry: China's economic growth is slowing down, but the medical device industry is still on the rise. The Chinese medical device industry was valued at US$18.8 billion in 2016 and is projected to grow modestly through 2019, when it should reach over US$24 billion.
The Chinese medical device market is buoyed by the increasing demand for high-tech medical device imports to treat chronic and age-related disease. Also, China's 13th Five-Year Plan prioritizes health and innovation, which will improve prospects for foreign medical device manufacturers.
Opportunities in the Chinese market: Chinese medical device manufacturers dominate the domestic market, but they deliver mostly low-tech and mid-range products. Chinese hospitals and healthcare providers prefer imported devices, especially when purchasing innovative and high-tech devices. Significant demand for foreign-made, high-end devices is also fueled by China's aging population continues to grow, and the Chinese government pushes to improve the quality of care.
Industry challenges in China: The volatile regulatory system in China presents a significant challenge for foreign manufacturers. Chinese regulations change rapidly and foreign manufacturers must comply with obscure requirements to enter the Chinese market. Successful entry may even require setting up a representative office and your own trading company, so China may be out of reach for small or start-up companies with limited investment capital. Despite these obstacles, China is still regarded as one of the most promising medical device markets in the world.
| CHINA | UNITED STATES | JAPAN | |
|---|---|---|---|
| Population | 1,367,485,388 | 321,368,864 | 126,919,659 |
| Primary language(s) | Chinese, Mandarin | English | Japanese |
| Total healthcare spending | $574 billion | $3 trillion | $469 billion |
| Healthcare expenditures total (% of GDP) | 5.5% | 17.1% | 10.2% |
| Healthcare expenditures per capita | $420 (USD) | $9403 (USD) | $3703 (USD) |
| Expenditures on healthcare | Government: 56% Private: 44% |
Government: 48% Private: 52% |
Government: 84% Private: 16% |
| Size of medical device market (USD) | $8.7 billion (USD) | $147.7 billion (USD) | $26 billion (USD) |
| Number of hospital beds | 3.8 per 1000 people | 2.9 per 1000 people | 13.7 per 1000 people |
| Age distribution | 0-14 years: 17% 15-64 years: 73% 65 years and over: 10% (2015 est.) |
0-14 years: 19% 15-64 years: 66% 65 years and over: 15% (2015 est.) |
0-14 years: 13% 15-64 years: 60% 65 years and over: 27% (2015 est.) |
| Life expectancy at birth | Male: 73 years Female: 78 years |
Male: 77 years Female: 82 years |
Male: 81 years Female: 88 years |
| Currency | Renminbi yuan (￥) | US dollar ($) | Yen |
Want to see how China compares to countries in Europe and around the world? Download our free PDF Healthcare spending by country.
自2018年起，美国食品和药物管理局（U.S. Food and Drug Administration，FDA）开始试行以电子化方式来帮助行业提供完整的510(k)上市前通知。2022年，为推进以电子格式提供510(k)递交文件的过渡，美国FDA正式发布关于使用电子递交模板和资源的最终指导文
阅读更多您的公司为符合欧盟医疗器械法规（MDR）作了哪些准备？ 在MDR规定下，医疗器械CE认证要求发生了重大变化，因此，医疗器械公司应当清楚地了解其合规程度，以及他们仍需采取哪些措施才能确保遵守新法规并维持欧盟市场准入资格。 我们的欧盟MDR准备情况检查表可以帮助您评估您
阅读更多